TERREMOTO
Live / Registered — Registered (as of 06 Oct 2026)
What this means for you
Registered since 06 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 06 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 97697582
- Registration number
- 8486982
- Mark type
- Design + words
- Filed
- 30 Nov 2022
- Published for opposition
- 21 May 2024
- Registered
- 06 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 06 Oct 2032 (grace period to 06 Apr 2033)
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceuticals for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of blood, hematologic, vascular, diseases, disorders and conditions; medicines for the prevention and treatment of cancer, oncological diseases, disorders and conditions; medicines for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions; drugs for the prevention and treatment of cancer, oncological diseases, disorders and conditions; drugs for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions; drug compounds for the prevention and treatment of cancer, oncological diseases, disorders and conditions; drug compounds for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions; small molecules for the prevention and treatment of cancer, oncological diseases, disorders and conditions; small molecules for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions; therapeutics for the prevention and treatment of cancer, oncological diseases, disorders and conditions; therapeutics for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions
- Class 042 — Scientific and technological services: Drug discovery and development services; scientific, medical, biotechnology, biomedical, medicinal chemistry, and pharmaceutical research and development services; scientific and medical testing services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; research, development, discovery and consulting services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; medical research; clinical research and development services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; medical and scientific research, namely, conducting and evaluating clinical trials for others; providing information about medical and scientific research; providing scientific information in the fields of medicine; and pharmaceuticals
Owner
- TERREMOTO BIOSCIENCES, INC., South San Francisco, CA, US
- TERREMOTO BIOSCIENCES, INC., South San Francisco, CA, US
- TERREMOTO BIOSCIENCES, INC., SAN FRANCISCO, CA, US
- TERREMOTO BIOSCIENCES, INC., San Francisco, CA, US
Prosecution history
- 06 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 11 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Jul 2026 — USE AMENDMENT FILED
- 26 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 09 Jul 2026 — SOU EXTENSION 4 GRANTED
- 09 Jul 2026 — SOU EXTENSION 4 FILED
- 09 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jan 2026 — SOU EXTENSION 3 GRANTED
- 13 Jan 2026 — SOU EXTENSION 3 FILED